Search:

Pharmaceuticals Headlines from PR Newswire


< Go Back

Actavis Confirms Appeals Court Issues Injunction Related to Generic Pulmicort RESPULES® Distribution
Building Medical Affairs Capabilities to Ensure Organizational Success across Key Operational Areas
Avella Founder and CEO John Musil Selected as Ernst & Young Entrepreneur Of The Year® 2013 Finalist
Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference
Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements
Sangamo BioSciences Receives $6.4 Million Strategic Partnership Award From California Institute for Regenerative Medicine (CIRM) to Develop ZFP Therapeutic® for Beta-thalassemia
Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference
China Biologic Comments on the Proposed Shanghai RAAS Transaction
PBAC Approves XIFAXAN® (Rifaxamin α) 550 mg Cost Effectiveness in Australia
Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines
Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany
Heptares Augments Business Development Capabilities in Japan and Other Asian Territories
3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement
Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland
Amgen to Present at the Deutsche Bank 38th Annual Healthcare Conference
Macrocyclics to Collaborate with Roche on Molecular Innovation for Nuclear Medicine
Neurocrine Biosciences to Present At The Deutsche Bank 38th Annual dbAccess Health Care Conference
Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions
Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support
Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog
Press Statement on Behalf of the Singh Family (The Former Shareholders and Founders of Ranbaxy)
Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients
Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers
Intercept Pharmaceuticals to Present at Deutsche Bank Healthcare Conference
Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer
Cardinal Health Selects Datameer for Healthcare Data Discovery
Johnson & Johnson Pharmaceuticals Segment Poised to Continue Driving Growth with More than 10 Potential New Product Filings by 2017
Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML)
MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy
Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference
Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease
Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share
OncoGenex Announces Plans for the Initiation of the Cedar™ Clinical Trial Evaluating OGX-427 in Combination with Chemotherapy in Advanced Squamous Cell Lung Cancer
PAREXEL International To Present At Jefferies Healthcare Conference
Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013
Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers
Heska Corporation to Present at the Stifel Dental & Veterinary Conference
Amgen Announces Voting Results of Annual Meeting of Stockholders
Hepatitis Awareness: Bringing Attention to a Silent Epidemic
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc.
The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients
Lupus Research Institute Hosts First International Conference to Advance New Treatments for Lupus Nephritis
Modern Medical Introduces Opioid Abuse Solution to the Workers' Compensation Industry
Annual Healthcare Cost for a Typical American Family is $22,030 According to 2013 Milliman Medical Index
Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine
Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site
JOT Automation Has Delivered Manufacturing Solution for Tandem Diabetes Care
Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance
Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures

< Prev Next >
PR Newswire - United Business Media